За пределами рака лёгкого: биспецифическое антитело Akeso покоряет новые рубежи в онкологии - The Pharma Media
За пределами рака лёгкого: биспецифическое антитело Akeso покоряет новые рубежи в онкологии The Pharma Media
Онкология
🎗️Лента новостей
Онкология
A new drug targeting KRAS, one of the key drivers of pancreatic cancer, is raising hopes after promising trial results. Rasonque has been approved in the USA, with a price tag of nearly $39,800 a month. Here’s why doctors are excited and what it could mean f - linkedin.com
A new drug targeting KRAS, one of the key drivers of pancreatic cancer, is raising hopes after promising trial results. Rasonque has been approved in the USA, with a price tag of nearly $39,800 a month. Here’s why doctors are excited and what it could mean f linkedin.com
Онкология
Cancer's malignant remote control: How tumors reprogram liver fat metabolism to disarm immune cells
In their quest to understand how cancers take root, grow and spread, scientists have for the past half-century explored the genetic aberrations and microenvironmental peculiarities of tumors and their constituent cells. Such studies continue to yield discoveries that are fueling a revolution in cancer therapy…
🎗️
Онкология
Dr. Tobias Janowitz joins Feinstein Institutes as new Institute of Cancer Research director - Business Wire
Dr. Tobias Janowitz joins Feinstein Institutes as new Institute of Cancer Research director Business Wire
Онкология
Cancer trials: Early-stage disease is underrepresented in open protocols - verahealth.ai
Cancer trials: Early-stage disease is underrepresented in open protocols verahealth.ai
Онкология
Свыше 550 жителей Подмосковья стали участниками акции по диагностике рака кожи - radio1.ru
Свыше 550 жителей Подмосковья стали участниками акции по диагностике рака кожи radio1.ru
Онкология
В России заявили о скорой победе над несколькими видами рака. В основу лечения ляжет новая терапия - Здоровье Mail
В России заявили о скорой победе над несколькими видами рака. В основу лечения ляжет новая терапия Здоровье Mail
Онкология
A 'one-two punch' against aggressive breast cancer could offer an alternative to chemotherapy
Triple-negative breast cancer (TNBC) has a frustrating ability to adapt. Although this aggressive form of breast cancer can initially respond well to chemotherapy, cancer cells often find ways to survive, allowing the disease to return and become resistant to treatment.
Онкология
За пределами рака лёгкого: биспецифическое антитело Akeso покоряет новые рубежи в онкологии - The Pharma Media
За пределами рака лёгкого: биспецифическое антитело Akeso покоряет новые рубежи в онкологии The Pharma Media
Онкология
Naoto Ueno: IAEA Names University of Hawaiʻi Cancer Center Body Composition Laboratory as Collaborating Center - Oncodaily
Naoto Ueno: IAEA Names University of Hawaiʻi Cancer Center Body Composition Laboratory as Collaborating Center Oncodaily
Онкология
У россиян нашли ген, который повышает риск развития осложнений при лечении рака - Здоровье Mail
У россиян нашли ген, который повышает риск развития осложнений при лечении рака Здоровье Mail
🎗️
Онкология
Column | I’m an oncologist. Every man should know this about prostate cancer. - The Washington Post
Column | I’m an oncologist. Every man should know this about prostate cancer. The Washington Post
Онкология
Xenograft Model Selection and Standardization Across CDX, PDX, Humanized, and Organoid-Derived Models in Preclinical Cancer Research - Yahoo Finance
Xenograft Model Selection and Standardization Across CDX, PDX, Humanized, and Organoid-Derived Models in Preclinical Cancer Research Yahoo Finance